Journal
BREAST
Volume 21, Issue 5, Pages 678-681Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.breast.2012.06.013
Keywords
Sentinel lymph node biopsy (SLNB); Breast cancer treatment; Ultra-sound; Axillary surgery
Categories
Funding
- Fondazione Umberto Veronesi (FUV)
- Fondazione Istituto Europeo di Oncologia (FIEO)
- Avon
Ask authors/readers for more resources
Sentinel lymph node biopsy (SLNB) is the standard approach for axillary staging in patients with early breast cancer. Recent data showed no outcome difference in patients with positive sentinel node between axillary dissection vs no further axillary surgery, raising doubts on the role of SLNB itself. Therefore, a new trial was designed comparing SLNB vs observation when axillary ultra-sound is negative in patients with small breast cancer candidates to breast conserving surgery. (C) 2012 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available